118 related articles for article (PubMed ID: 37021821)
1. ERK2 Mutations Affect Interactions, Localization, and Dimerization.
Taylor CA; Cormier KW; Martin-Vega A; Earnest S; Stippec S; Wichaidit C; Cobb MH
Biochemistry; 2023 May; 62(9):1433-1442. PubMed ID: 37021821
[TBL] [Abstract][Full Text] [Related]
2. Functional divergence caused by mutations in an energetic hotspot in ERK2.
Taylor CA; Cormier KW; Keenan SE; Earnest S; Stippec S; Wichaidit C; Juang YC; Wang J; Shvartsman SY; Goldsmith EJ; Cobb MH
Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15514-15523. PubMed ID: 31296562
[TBL] [Abstract][Full Text] [Related]
3. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
Bardwell AJ; Abdollahi M; Bardwell L
Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
[TBL] [Abstract][Full Text] [Related]
4. Two clusters of residues at the docking groove of mitogen-activated protein kinases differentially mediate their functional interaction with the tyrosine phosphatases PTP-SL and STEP.
Tárrega C; Blanco-Aparicio C; Muñoz JJ; Pulido R
J Biol Chem; 2002 Jan; 277(4):2629-36. PubMed ID: 11711538
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor and protein kinase C signaling to ERK2: spatiotemporal regulation of ERK2 by dual specificity phosphatases.
Caunt CJ; Rivers CA; Conway-Campbell BL; Norman MR; McArdle CA
J Biol Chem; 2008 Mar; 283(10):6241-52. PubMed ID: 18178562
[TBL] [Abstract][Full Text] [Related]
6. Mutation in the Common Docking Domain Affects MAP Kinase ERK2 Catalysis and Stability.
Novak L; Petrosino M; Pasquo A; Chaikuad A; Chiaraluce R; Knapp S; Consalvi V
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296900
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel point mutations in ERK2 that selectively disrupt binding to MEK1.
Robinson FL; Whitehurst AW; Raman M; Cobb MH
J Biol Chem; 2002 Apr; 277(17):14844-52. PubMed ID: 11823456
[TBL] [Abstract][Full Text] [Related]
8. Common docking domain mutation E322K of the ERK2 gene is infrequent in oral squamous cell carcinomas.
Valiathan GM; Thenumgal SJ; Jayaraman B; Palaniyandi A; Ramkumar H; Jayakumar K; Bhaskaran S; Ramanathan A
Asian Pac J Cancer Prev; 2012; 13(12):6155-7. PubMed ID: 23464422
[TBL] [Abstract][Full Text] [Related]
9. A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates.
Zhang J; Zhou B; Zheng CF; Zhang ZY
J Biol Chem; 2003 Aug; 278(32):29901-12. PubMed ID: 12754209
[TBL] [Abstract][Full Text] [Related]
10. ERK2 shows a restrictive and locally selective mechanism of recognition by its tyrosine phosphatase inactivators not shared by its activator MEK1.
Tárrega C; Ríos P; Cejudo-Marín R; Blanco-Aparicio C; van den Berk L; Schepens J; Hendriks W; Tabernero L; Pulido R
J Biol Chem; 2005 Nov; 280(45):37885-94. PubMed ID: 16148006
[TBL] [Abstract][Full Text] [Related]
11. Hydrophobic as well as charged residues in both MEK1 and ERK2 are important for their proper docking.
Xu Be ; Stippec S; Robinson FL; Cobb MH
J Biol Chem; 2001 Jul; 276(28):26509-15. PubMed ID: 11352917
[TBL] [Abstract][Full Text] [Related]
12. Local destabilization, rigid body, and fuzzy docking facilitate the phosphorylation of the transcription factor Ets-1 by the mitogen-activated protein kinase ERK2.
Piserchio A; Warthaka M; Kaoud TS; Callaway K; Dalby KN; Ghose R
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):E6287-E6296. PubMed ID: 28716922
[TBL] [Abstract][Full Text] [Related]
13. Spatiotemporal regulation of ERK2 by dual specificity phosphatases.
Caunt CJ; Armstrong SP; Rivers CA; Norman MR; McArdle CA
J Biol Chem; 2008 Sep; 283(39):26612-23. PubMed ID: 18650424
[TBL] [Abstract][Full Text] [Related]
14. Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes.
Eblen ST; Slack JK; Weber MJ; Catling AD
Mol Cell Biol; 2002 Sep; 22(17):6023-33. PubMed ID: 12167697
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of ERK2 interactions with substrate proteins: roles for kinase docking domains and activity in determining binding affinity.
Burkhard KA; Chen F; Shapiro P
J Biol Chem; 2011 Jan; 286(4):2477-85. PubMed ID: 21098038
[TBL] [Abstract][Full Text] [Related]
16. Extracellular signal-regulated kinase 2 (ERK2) phosphorylation sites and docking domain on the nuclear pore complex protein Tpr cooperatively regulate ERK2-Tpr interaction.
Vomastek T; Iwanicki MP; Burack WR; Tiwari D; Kumar D; Parsons JT; Weber MJ; Nandicoori VK
Mol Cell Biol; 2008 Nov; 28(22):6954-66. PubMed ID: 18794356
[TBL] [Abstract][Full Text] [Related]
17. Mutations in ERK2 binding sites affect nuclear entry.
Yazicioglu MN; Goad DL; Ranganathan A; Whitehurst AW; Goldsmith EJ; Cobb MH
J Biol Chem; 2007 Sep; 282(39):28759-28767. PubMed ID: 17656361
[TBL] [Abstract][Full Text] [Related]
18. Kinetic network model to explain gain-of-function mutations in ERK2 enzyme.
Misiura M; Kolomeisky AB
J Chem Phys; 2019 Apr; 150(15):155101. PubMed ID: 31005085
[TBL] [Abstract][Full Text] [Related]
19. The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactions.
Whitehurst AW; Robinson FL; Moore MS; Cobb MH
J Biol Chem; 2004 Mar; 279(13):12840-7. PubMed ID: 14707138
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-releasing hormone and protein kinase C signaling to ERK: spatiotemporal regulation of ERK by docking domains and dual-specificity phosphatases.
Armstrong SP; Caunt CJ; McArdle CA
Mol Endocrinol; 2009 Apr; 23(4):510-9. PubMed ID: 19179479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
